Cargando…

Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008

BACKGROUND: Macrolide resistant Streptococcus pneumoniae has been on a gradual increase in Germany for over a decade. The current study was undertaken against the background of the recent observation of declining macrolide resistance rates especially among German children. Nationwide surveillance of...

Descripción completa

Detalles Bibliográficos
Autores principales: Imöhl, Matthias, Reinert, Ralf René, Mutscher, Christina, van der Linden, Mark
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001718/
https://www.ncbi.nlm.nih.gov/pubmed/21108778
http://dx.doi.org/10.1186/1471-2180-10-299
_version_ 1782193652746944512
author Imöhl, Matthias
Reinert, Ralf René
Mutscher, Christina
van der Linden, Mark
author_facet Imöhl, Matthias
Reinert, Ralf René
Mutscher, Christina
van der Linden, Mark
author_sort Imöhl, Matthias
collection PubMed
description BACKGROUND: Macrolide resistant Streptococcus pneumoniae has been on a gradual increase in Germany for over a decade. The current study was undertaken against the background of the recent observation of declining macrolide resistance rates especially among German children. Nationwide surveillance of invasive pneumococcal disease has been conducted in Germany since 1992. A population- and laboratory-based approach was used to collect data on invasive pneumococcal disease, and isolates sent to the National Reference Center for Streptococci by diagnostic microbiological laboratories from 1992 to 2008 were included in this study. RESULTS: From 1992 to 2008, data on macrolide susceptibility were available for 11,807 invasive isolates. 8,834 isolates (74.8%) were from adults (≥ 16 years), and 2,973 isolates (25.2%) from children (< 16 years). The overall nonsusceptibility rate of all isolates was 16.2% (intermediate, 0.2%; resistant, 16.0%). Higher resistance rates were observed among children (intermediate, 0.2%; resistant, 23.8%) than among adults (intermediate, 0.3%; resistant 13.4%). Maximum nonsusceptibility rates during the period under study were observed in 2005 (children: intermediate, 0.3%; resistant, 32.3%; adults: intermediate, 0.0%; resistant, 18.6%), while nonsusceptibility rates in 2008 were considerably lower, especially for children (children: intermediate, 0.0%; resistant, 15.2%; adults: intermediate, 0.1%; resistant, 12.9%). The rate of resistance was higher among the vaccine serotypes (7-valent, 36.6%; 10-valent, 28.2%; 13-valent, 24.3%) than among the non vaccine serotypes (non 7-valent, 6.5%; non 10-valent, 7.4%; non 13-valent, 6.3%). Serotype 14 (69.6% nonsusceptibility) proved to be the most resistant serotype. CONCLUSIONS: There has been a considerable and statistically significant decrease in macrolide nonsusceptibility in Germany since 2005, especially among children.
format Text
id pubmed-3001718
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30017182010-12-15 Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008 Imöhl, Matthias Reinert, Ralf René Mutscher, Christina van der Linden, Mark BMC Microbiol Research Article BACKGROUND: Macrolide resistant Streptococcus pneumoniae has been on a gradual increase in Germany for over a decade. The current study was undertaken against the background of the recent observation of declining macrolide resistance rates especially among German children. Nationwide surveillance of invasive pneumococcal disease has been conducted in Germany since 1992. A population- and laboratory-based approach was used to collect data on invasive pneumococcal disease, and isolates sent to the National Reference Center for Streptococci by diagnostic microbiological laboratories from 1992 to 2008 were included in this study. RESULTS: From 1992 to 2008, data on macrolide susceptibility were available for 11,807 invasive isolates. 8,834 isolates (74.8%) were from adults (≥ 16 years), and 2,973 isolates (25.2%) from children (< 16 years). The overall nonsusceptibility rate of all isolates was 16.2% (intermediate, 0.2%; resistant, 16.0%). Higher resistance rates were observed among children (intermediate, 0.2%; resistant, 23.8%) than among adults (intermediate, 0.3%; resistant 13.4%). Maximum nonsusceptibility rates during the period under study were observed in 2005 (children: intermediate, 0.3%; resistant, 32.3%; adults: intermediate, 0.0%; resistant, 18.6%), while nonsusceptibility rates in 2008 were considerably lower, especially for children (children: intermediate, 0.0%; resistant, 15.2%; adults: intermediate, 0.1%; resistant, 12.9%). The rate of resistance was higher among the vaccine serotypes (7-valent, 36.6%; 10-valent, 28.2%; 13-valent, 24.3%) than among the non vaccine serotypes (non 7-valent, 6.5%; non 10-valent, 7.4%; non 13-valent, 6.3%). Serotype 14 (69.6% nonsusceptibility) proved to be the most resistant serotype. CONCLUSIONS: There has been a considerable and statistically significant decrease in macrolide nonsusceptibility in Germany since 2005, especially among children. BioMed Central 2010-11-25 /pmc/articles/PMC3001718/ /pubmed/21108778 http://dx.doi.org/10.1186/1471-2180-10-299 Text en Copyright ©2010 Imöhl et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Imöhl, Matthias
Reinert, Ralf René
Mutscher, Christina
van der Linden, Mark
Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008
title Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008
title_full Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008
title_fullStr Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008
title_full_unstemmed Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008
title_short Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008
title_sort macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of streptococcus pneumoniae in germany from 1992 to 2008
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001718/
https://www.ncbi.nlm.nih.gov/pubmed/21108778
http://dx.doi.org/10.1186/1471-2180-10-299
work_keys_str_mv AT imohlmatthias macrolidesusceptibilityandserotypespecificmacrolideresistanceofinvasiveisolatesofstreptococcuspneumoniaeingermanyfrom1992to2008
AT reinertralfrene macrolidesusceptibilityandserotypespecificmacrolideresistanceofinvasiveisolatesofstreptococcuspneumoniaeingermanyfrom1992to2008
AT mutscherchristina macrolidesusceptibilityandserotypespecificmacrolideresistanceofinvasiveisolatesofstreptococcuspneumoniaeingermanyfrom1992to2008
AT vanderlindenmark macrolidesusceptibilityandserotypespecificmacrolideresistanceofinvasiveisolatesofstreptococcuspneumoniaeingermanyfrom1992to2008